Valuation Colinz Laboratories Limited

Stocks

Market Closed - Bombay S.E. Other stock markets 11:01:02 03/07/2026 BST			5-day change	1st Jan Change
77.55 ^INR	-5.00%		+2.65%	+44.60%

06-17	Annjana Dugar, Likhitta Dugar and Antariksh Dugar executed of Share Purchase Agreement to acquire an additional 34.56% stake in Colinz Laboratories Limited from Vijaya Mani for INR 43.5 million,	CI
06-17	Annjana Dugar, Likhitta Dugar and Antariksh Dugar proposed to acquire an additional 26% stake in Colinz Laboratories Limited for INR 35.4 million.	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2020	2021	2022	2023	2024	2025
Market Cap ¹	40.82	34.74	107.6	160	94.59	182.5
Change	-	-14.89%	209.87%	48.62%	-40.87%	92.92%
Enterprise Value (EV) ¹	18.65	-2.149	60.43	105.4	30.29	133.4
Change	-	-111.53%	2,911.96%	74.47%	-71.27%	340.39%
P/E	31.3x	16.7x	31.8x	19.2x	19.5x	36.8x
PBR	0.6x	0.48x	1.4x	1.08x	1.06x	1.93x
PEG	-	0.3x	0.5x	0x	3.23x	17.76x
Capitalization / Revenue	0.54x	0.56x	1.54x	2.24x	1.35x	2.8x
EV / Revenue	0.25x	-0.03x	0.87x	1.47x	0.43x	2.04x
EV / EBITDA	6.16x	-0.65x	10.3x	16.7x	5.58x	26.9x
EV / EBIT	17.3x	-1.52x	15.7x	20.9x	7.34x	36.7x
EV / FCF	2.68x	-0.2x	8.87x	17.8x	4.12x	-7.62x
FCF Yield	37.3%	-506%	11.3%	5.62%	24.3%	-13.1%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	0.2854	0.4541	0.74	1.82	1.93	1.97
Distribution rate	-	-	-	-	-	-
Net sales ¹	76.03	61.59	69.74	71.55	70.3	65.28
EBITDA ¹	3.027	3.331	5.862	6.326	5.428	4.951
EBIT ¹	1.079	1.418	3.85	5.037	4.125	3.639
Net income ¹	1.304	2.076	3.393	4.574	4.867	4.966
Net Debt ¹	-22.17	-36.89	-47.22	-54.55	-64.3	-49.09
Reference price ²	8.93	7.60	23.55	35.00	37.55	72.44
Nbr of stocks (in thousands)	4,571	4,571	4,571	4,571	2,519	2,519
Announcement Date	02/09/20	30/08/21	24/08/22	29/08/23	29/08/24	28/08/25

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
COLINZ LABORATORIES LIMITED	-	-	-	-	2.05M
SUN PHARMACEUTICAL INDUSTRIES LTD.	39.29x	7.46x	25.43x	0.79%	48B
OTSUKA HOLDINGS CO., LTD.	18.78x	2.12x	10.01x	1.29%	36.89B
CIPLA LIMITED	28.07x	3.47x	17.79x	0.86%	12.37B
ZYDUS LIFESCIENCES LIMITED	25.01x	4.33x	16.13x	0.71%	11.95B
KRKA, D. D.	19.52x	3.37x	12.24x	3.5%	9.01B
GEDEON RICHTER	8.51x	2.01x	5.25x	5.09%	7.2B
ONO PHARMACEUTICAL CO., LTD.	16.15x	2.07x	6.97x	3.24%	7.05B
GLENMARK PHARMACEUTICALS LIMITED	33.56x	3.82x	16.25x	0.24%	6.55B
Average	23.61x	3.58x	13.76x	1.96%	15.45B
Weighted average by Cap.	27.31x	4.43x	16.59x	1.42%